| Epidemiology and risk factors of osteosarcoma LR Sadykova, AI Ntekim, M Muyangwa-Semenova, CS Rutland, ... Cancer investigation 38 (5), 259-269, 2020 | 173 | 2020 |
| Cervical cancer in sub Sahara Africa A Ntekim Topics on cervical cancer with an advocacy for prevention 4, 54-59, 2012 | 103 | 2012 |
| Breast cancer in young women in Ibadan, Nigeria A Ntekim, FT Nufu, OB Campbell African health sciences 9 (4), 2009 | 96 | 2009 |
| Regulation of vascular endothelial growth factor in prostate cancer S de Brot, A Ntekim, R Cardenas, V James, C Allegrucci, DM Heery, ... Endocrine-related cancer 22 (3), R107-R123, 2015 | 58 | 2015 |
| Optimal management of cervical cancer in HIV‐positive patients: a systematic review A Ntekim, O Campbell, D Rothenbacher Cancer medicine 4 (9), 1381-1393, 2015 | 52 | 2015 |
| High Dose Rate Brachytherapy in the Treatment of Cervical Cancer: Preliminary Experience with Cobalt 60 Radionuclide Source—A Prospective Study A Ntekim, A Adenipekun, B Akinlade, O Campbell Clinical Medicine Insights: Oncology 4, CMO. S5269, 2010 | 42 | 2010 |
| Barriers to radiotherapy access at the University College Hospital in Ibadan, Nigeria CP Anakwenze, A Ntekim, B Trock, IB Uwadiae, BR Page Clinical and translational radiation oncology 5, 1-5, 2017 | 32 | 2017 |
| Angiogenic activity of cytochalasin B-induced membrane vesicles of human mesenchymal stem cells MO Gomzikova, MN Zhuravleva, VV Vorobev, II Salafutdinov, AV Laikov, ... Cells 9 (1), 95, 2019 | 28 | 2019 |
| Infrastructural challenges lead to delay of curative radiotherapy in Nigeria J Leng, AI Ntekim, A Ibraheem, CP Anakwenze, DW Golden, OI Olopade JCO global oncology 6, 269-276, 2020 | 27 | 2020 |
| Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin M Faruk, S Ibrahim, SM Aminu, A Adamu, A Abdullahi, AM Suleiman, ... Plos one 16 (1), e0245581, 2021 | 17 | 2021 |
| Implementing oncology clinical trials in Nigeria: a model for capacity building A Ntekim, A Ibraheem, A Adeniyi-Sofoluwe, T Adepoju, M Oluwasanu, ... BMC Health Services Research 20, 1-9, 2020 | 16 | 2020 |
| The METTL3 RNA methyltransferase regulates transcriptional networks in prostate cancer DB Haigh, CL Woodcock, J Lothion-Roy, AE Harris, VM Metzler, ... Cancers 14 (20), 5148, 2022 | 12 | 2022 |
| Characteristics and Determinants of Patients' Discontinuation of Breast Cancer Follow up Care at Radiation Oncology Department, University College Hospital Ibadan Nigeria AO Dairo md, Adamu db, Onimode ya, Ntekim I International Journal of Breast Cancer 9, 1-9, 2018 | 12* | 2018 |
| Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer AE Harris, VM Metzler, J Lothion-Roy, D Varun, CL Woodcock, DB Haigh, ... Frontiers in endocrinology 13, 1006101, 2022 | 11 | 2022 |
| Breast cancer in adolescents and young adults less than 40 years of age in Nigeria: A retrospective analysis A Ntekim, M Oluwasanu, O Odukoya International journal of breast cancer 2022, 2022 | 11 | 2022 |
| Cancer and COVID-19 experiences at African cancer centers: the silver lining L Grossheim, P Ruff, T Ngoma, V Vanderpuye, G Mwango, P Ochieng, ... JCO global oncology 7 (1), 410-415, 2021 | 11 | 2021 |
| Survival pattern of rare histological types of breast cancer in a Nigerian institution AI Ntekim, AM Folasire, M Ali-Gombe Pan African Medical Journal 34 (1), 2019 | 11 | 2019 |
| An analysis of dietary fiber and fecal fiber components including pH in rural Africans with colorectal cancer M Faruk, S Ibrahim, A Adamu, AH Rafindadi, Y Ukwenya, Y Iliyasu, ... Intestinal research 16 (1), 99, 2018 | 11 | 2018 |
| Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria M Ali-Gombe, MI Mustapha, A Folasire, A Ntekim, OB Campbell ecancermedicalscience 15, 2021 | 10 | 2021 |
| CD4 count and anti retroviral therapy for HIV positive patients with cancer in Nigeria-A Pilot Study AI Ntekim, AM Folasire Clinical Medicine Insights: Oncology 4, CMO. S5028, 2010 | 10 | 2010 |
